An Observational Study On Madhumegam (Diabetes Mellitus) With Good And Poor Glycemic Control In Accordance With Neerkuri(Characteristics of Urine) And Neikkuri
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2021/08/035868
- Lead Sponsor
- Government Siddha Medical College and Hospital Palayamkottai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who are already diagnosed with Madhumegam
For good glycemic control HbA1c below or upto 7%
For poor glcemic control HbA1c above 7%
Exclusion Criteria
Gestational Diabetes
Lactating mother
Diabetes insipidus
Type 1 Diabetes Mellitus
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing siddha diagnostic methodology especially neerkuri and neikkuri in MadhumegamTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method Manikadai nool and Naadi nadai are used for the diagnosis of Madhumegam <br/ ><br>Making treatment easy by framing prompt diagnosis <br/ ><br>To prevent complications related to the diseaseTimepoint: 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glycemic control in Siddha medicine for type 2 diabetes mellitus with complications?
How does Siddha-based Neerkuri and Neikkuri assessment compare to standard-of-care in predicting diabetes outcomes?
Are there specific biomarkers in Siddha parameters that correlate with response to traditional treatments in type 2 diabetes patients?
What adverse events are associated with Siddha interventions for diabetes mellitus and how are they managed?
What combination therapies or compounds in Siddha medicine show potential for improving glycemic control in type 2 diabetes with complications?